These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22895471)

  • 1. Determining optimal cytotoxic activity of human Her2neu specific CD8 T cells by comparing the Cr51 release assay to the xCELLigence system.
    Erskine CL; Henle AM; Knutson KL
    J Vis Exp; 2012 Aug; (66):e3683. PubMed ID: 22895471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An impedance-based cytotoxicity assay for real-time and label-free assessment of T-cell-mediated killing of adherent cells.
    Peper JK; Schuster H; Löffler MW; Schmid-Horch B; Rammensee HG; Stevanović S
    J Immunol Methods; 2014 Mar; 405():192-8. PubMed ID: 24486140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.
    Hundemer M; Schmidt S; Condomines M; Lupu A; Hose D; Moos M; Cremer F; Kleist C; Terness P; Belle S; Ho AD; Goldschmidt H; Klein B; Christensen O
    Exp Hematol; 2006 Apr; 34(4):486-96. PubMed ID: 16569595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive flow cytometry-based cytotoxic T-lymphocyte assay through detection of cleaved caspase 3 in target cells.
    He L; Hakimi J; Salha D; Miron I; Dunn P; Radvanyi L
    J Immunol Methods; 2005 Sep; 304(1-2):43-59. PubMed ID: 16076473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
    Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
    J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
    Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
    Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous production of T helper-1-like cytokines and cytolytic activity by tumor-specific T cells in ovarian and breast cancer.
    Goedegebuure PS; Douville CC; Doherty JM; Linehan DC; Lee KY; Ganguly EK; Eberlein TJ
    Cell Immunol; 1997 Feb; 175(2):150-6. PubMed ID: 9023420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal diversity of the T-cell population responding to a dominant HLA-A2 epitope of HER-2/neu after active immunization in an ovarian cancer patient.
    Knutson KL; Disis ML
    Hum Immunol; 2002 Jul; 63(7):547-57. PubMed ID: 12072190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic Activity and Memory T Cell Subset Distribution of
    Kuznetsova M; Lopatnikova J; Shevchenko J; Silkov A; Maksyutov A; Sennikov S
    Front Immunol; 2019; 10():1017. PubMed ID: 31143180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo.
    Tu SH; Huang HI; Lin SI; Liu HY; Sher YP; Chiang SK; Chong P; Roffler S; Tseng GC; Chen HW; Liu SJ
    J Immunother; 2012 Apr; 35(3):235-44. PubMed ID: 22421941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BLT esterase activity as an alternative to chromium release in cytotoxic T cell assays.
    Suhrbier A; Fernan A; Burrows SR; Saul A; Moss DJ
    J Immunol Methods; 1991 Dec; 145(1-2):43-53. PubMed ID: 1722495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients.
    Jaramillo A; Narayanan K; Campbell LG; Benshoff ND; Lybarger L; Hansen TH; Fleming TP; Dietz JR; Mohanakumar T
    Breast Cancer Res Treat; 2004 Nov; 88(1):29-41. PubMed ID: 15538043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes.
    Traidl C; Sebastiani S; Albanesi C; Merk HF; Puddu P; Girolomoni G; Cavani A
    J Immunol; 2000 Sep; 165(6):3058-64. PubMed ID: 10975816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific, but not natural killer, activity of T cell receptor-gamma delta cytotoxic T lymphocyte clones involves secretion of N alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester serine esterase and influx of Ca2+ ions.
    Spits H; Paliard X; De Vries JE
    J Immunol; 1989 Sep; 143(5):1506-11. PubMed ID: 2474601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes.
    Sandberg JK; Fast NM; Nixon DF
    J Immunol; 2001 Jul; 167(1):181-7. PubMed ID: 11418647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel immunogenic HLA-A*0201-binding epitope of HER-2/neu with potent antitumor properties.
    Gritzapis AD; Voutsas IF; Lekka E; Tsavaris N; Missitzis I; Sotiropoulou P; Perez S; Papamichail M; Baxevanis CN
    J Immunol; 2008 Jul; 181(1):146-54. PubMed ID: 18566379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous immunity against Bcl-xL in cancer patients.
    Andersen MH; Reker S; Kvistborg P; Becker JC; thor Straten P
    J Immunol; 2005 Aug; 175(4):2709-14. PubMed ID: 16081848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTL ELISPOT assay.
    Ranieri E; Popescu I; Gigante M
    Methods Mol Biol; 2014; 1186():75-86. PubMed ID: 25149304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cytotoxic T-lymphocytes specific for malignant glioma by HLA dimer-based artificial antigen-presenting cells.
    Xiaobing J; Xiaoling L; Ruen L; Fangcheng Z; Hongyang Z
    Cancer Biother Radiopharm; 2007 Dec; 22(6):826-35. PubMed ID: 18158774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of immunodominant HLA-B7-restricted CD8+ cytotoxic T cell epitopes derived from mammaglobin-A expressed on human breast cancers.
    Ilias Basha H; Tiriveedhi V; Fleming TP; Gillanders WE; Mohanakumar T
    Breast Cancer Res Treat; 2011 May; 127(1):81-9. PubMed ID: 20544273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.